MEADE HARRY 4/A
4/A · GTC BIOTHERAPEUTICS INC · Filed Nov 13, 2009
Insider Transaction Report
Form 4/AAmended
MEADE HARRY
SVP, Transgenic Research
Transactions
- Award
Common Stock
2009-11-02$1.21/sh+15,403$18,638→ 31,257 total - Tax Payment
Common Stock
2009-11-02$1.21/sh−5,520$6,679→ 25,737 total
Holdings
- 5,302(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Reflects total bonus shares issuable, before forfeitures for tax withholding. The number of shares in the original Form 4 showed bonus shares issued, net of a number of shares forfeited for taxes.
- [F2]This is the correct number of shares forfeited for tax withholding. The original Form 4 did not show share forfeitures or reflect the correct number of shares forfeited.